Skip to main content

Table 3 Age distribution of OCEAN participants who gave up driving generally or mainly due to eyesight issues, by indication

From: Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study

   Age group
Indication <30 30 - <40 40 - <50 50 - <60 60 - <70 70 - <80 80 - <90 90 - <100 ≥100
nAMD n 0 4 7 39 257 996 852 99 1
Gave up driving… [n (%)] 0 (0 %) 2 (50 %) 1 (14 %) 7 (18 %) 38 (15 %) 232 (23 %) 269 (32 %) 40 (40 %) 0 (0 %)
…mainly due to eyesight [n (%)] 0 (0 %) 1 (25 %) 1 (14 %) 4 (10 %) 20 (8 %) 112 (11 %) 110 (13 %) 11 (11 %) 0 (0 %)
DME n 1 11 31 110 172 259 63 3 0
Gave up driving… [n (%)] 0 (0 %) 2 (18 %) 4 (13 %) 23 (21 %) 40 (23 %) 55 (21 %) 18 (29 %) 1 (33 %) 0 (0 %)
…mainly due to eyesight [n (%)] 0 (0 %) 2 (18 %) 1 (3 %) 8 (7 %) 21 (12 %) 21 (8 %) 7 (11 %) 1 (33 %) 0 (0 %)
BRVO n 0 1 8 13 38 55 21 3 0
Gave up driving… [n (%)] 0 (0 %) 0 (0 %) 0 (0 %) 2 (15 %) 5 (13 %) 10 (18 %) 5 (24 %) 3 (100 %) 0 (0 %)
…mainly due to eyesight [n (%)] 0 (0 %) 0 (0 %) 0 (0 %) 1 (8 %) 3 (8 %) 3 (5 %) 1 (5 %) 1 (33 %) 0 (0 %)
CRVO n 0 1 1 11 19 32 15 1 0
Gave up driving… [n (%)] 0 (0 %) 1 (100 %) 0 (0 %) 2 (18 %) 3 (16 %) 4 (13 %) 3 (20 %) 1 (100 %) 0 (0 %)
…mainly due to eyesight [n (%)] 0 (0 %) 1 (100 %) 0 (0 %) 1 (9 %) 1 (5 %) 1 (3 %) 2 (13 %) 0 (0 %) 0 (0 %)
\